Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katzenstein

Showing results (651-660 of 874) with videos related to

Pageof 88
Sort By:
Journal of Virological Methods|June 4, 2009
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house methodS Saravanan, M Vidya, P Balakrishnan, et al.
The New England Journal of Medicine|February 22, 1990
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasiaR G Knowlton, P L Katzenstein, R W Moskowitz, et al.
The American Journal of Surgical Pathology|November 1, 1995
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infectionJ L Myers, P J Kurtin, A L Katzenstein, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 19, 2009
NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primaryBahig M Shehata, Charlotte K Steelman, Carlos R Abramowsky, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 26, 2020
Pediatric Teleneuropsychology: Feasibility and RecommendationsDanielle M Ransom, Sakina M Butt, Emily K DiVirgilio, et al.
Antiviral Therapy|November 18, 2009
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south IndiaMadhavan Vidya, Shanmugam Saravanan, Shanmugasundaram Uma, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Cancer|October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology GroupHoward M Katzenstein, Kay W Chang, Mark Krailo, et al.
Pageof 88

Showing results (651-660 of 874) with videos related to

Sort By:
Pageof 88
Journal of Virological Methods|June 4, 2009
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house methodS Saravanan, M Vidya, P Balakrishnan, et al.
The New England Journal of Medicine|February 22, 1990
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasiaR G Knowlton, P L Katzenstein, R W Moskowitz, et al.
The American Journal of Surgical Pathology|November 1, 1995
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infectionJ L Myers, P J Kurtin, A L Katzenstein, et al.
Annals of Internal Medicine|April 3, 1999
Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA studyV Miller, A Mocroft, P Reiss, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|December 19, 2009
NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primaryBahig M Shehata, Charlotte K Steelman, Carlos R Abramowsky, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 26, 2020
Pediatric Teleneuropsychology: Feasibility and RecommendationsDanielle M Ransom, Sakina M Butt, Emily K DiVirgilio, et al.
Antiviral Therapy|November 18, 2009
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south IndiaMadhavan Vidya, Shanmugam Saravanan, Shanmugasundaram Uma, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Cancer|October 9, 2009
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology GroupHoward M Katzenstein, Kay W Chang, Mark Krailo, et al.
Pageof 88